These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 25346093)

  • 1. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
    Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1723-31. PubMed ID: 24533503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.
    Lee JH; Park CJ; Kim TY; Choe YB; Kim NI; Song HJ; Youn JI; Youn SW; Choi JH; Kim KJ
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):483-489. PubMed ID: 27723134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
    Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
    Bagel J; Levi E; Tyring S; Knuckles ML
    J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
    Gual A; Pau-Charles I; Molin S
    J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
    J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
    Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
    Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL
    Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
    Liu L; Zhang C; Wang J; Chen K; Ding Y; Yan G; Lu Q; Li W; Fang H; Cheng H; Zhang J; He Y; Zhu W; Lu Y; Huang J; Pan W; Li M; Cao S; Li S; Han X; He L; Chen Y; Zheng M
    Eur J Dermatol; 2020 Oct; 30(5):580-590. PubMed ID: 33052103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.